Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders

Blood Adv. 2023 Nov 14;7(21):6767-6770. doi: 10.1182/bloodadvances.2023011063.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Breakthrough Infections
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Plasma Cells
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • COVID-19 breakthrough infections